$2.16
2.37% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US7530181004
Symbol
RANI
Sector
Industry

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock price

$2.16
-1.16 34.94% 1M
-0.87 28.71% 6M
-1.16 34.94% YTD
-0.64 22.86% 1Y
-16.21 88.24% 3Y
-8.84 80.36% 5Y
-8.84 80.36% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.05 2.37%
ISIN
US7530181004
Symbol
RANI
Sector
Industry

Key metrics

Market capitalization $61.80m
Enterprise Value $68.37m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 19.71
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-57.85m
Free Cash Flow (TTM) Free Cash Flow $-45.97m
Cash position $31.40m
EPS (TTM) EPS $-1.18
P/E forward negative
Short interest 4.64%
Show more

Is Rani Therapeutics Holdings Inc - Ordinary Shares Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Rani Therapeutics Holdings Inc - Ordinary Shares Class A forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Rani Therapeutics Holdings Inc - Ordinary Shares Class A forecast:

Buy
100%

Financial data from Rani Therapeutics Holdings Inc - Ordinary Shares Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
- -
-
100%
- Direct Costs 1.21 1.21
27% 27%
-
-1.21 -1.21
27% 27%
-
- Selling and Administrative Expenses 23 23
9% 9%
-
- Research and Development Expense 33 33
19% 19%
-
-57 -57
15% 15%
-
- Depreciation and Amortization 1.21 1.21
27% 27%
-
EBIT (Operating Income) EBIT -58 -58
16% 16%
-
Net Profit -31 -31
11% 11%
-

In millions USD.

Don't miss a Thing! We will send you all news about Rani Therapeutics Holdings Inc - Ordinary Shares Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock News

Neutral
GlobeNewsWire
24 days ago
SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in September 2024. These conferences include:
Neutral
GlobeNewsWire
about 2 months ago
- Announced partnership with ProGen on development of RT-114, an oral GLP-1/GLP-2 dual agonist for the treatment of obesity -
Neutral
GlobeNewsWire
2 months ago
SAN JOSE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in August 2024. These conferences include:
More Rani Therapeutics Holdings Inc - Ordinary Shares Class A News

Company Profile

Rani Therapeutics Holdings, Inc. operates as a clinical stage bio-therapeutics company providing technologies to enable the development of orally administered biologics. It offers RaniPill capsule, an orally ingestible pill for the administration of a broad range of biologics. The company was founded by Mir Imran on April 6, 2021 and is headquartered in San Jose, CA.

Head office United States
CEO Talat Imran
Employees 140
Founded 2012
Website www.ranitherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today